Cetuximab is an anti-epidermal growth factor receptor (EGFR) monoclonal antibody used as a single agent in patients with KRAS metastatic colorectal cancer, for which many patients acquire resistance. This evidence concerns the gene EGFR and metastatic colorectal cancer.